UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000031302
Receipt number R000035504
Scientific Title Metachronous gastric cancer prevention with aspirin:A multi-center randomized trial
Date of disclosure of the study information 2018/02/14
Last modified on 2020/04/10 14:41:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Metachronous gastric cancer prevention with aspirin:A multi-center randomized trial

Acronym

MEGA trial

Scientific Title

Metachronous gastric cancer prevention with aspirin:A multi-center randomized trial

Scientific Title:Acronym

MEGA trial

Region

Japan Asia(except Japan)


Condition

Condition

Patients who underwent endoscopic submucosal dissection (ESD) for early gastric cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We aim to test the hypothesis that aspirin can reduce the occurrence of metachronous gastric cancer after ESD.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cumulative incidence rate of metachronous gastric carcinoma at 5 years after ESD.

Key secondary outcomes

Adverse events rate
Histological evaluation of gastric mucosal atrophy and intestinal metaplasia
Microbiota changes in stool and oral swab


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Aspirin 81 mg once daily for up to 5 years

Interventions/Control_2

Nothing

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Achieved absolute or expanded curative resection with ESD defined as per JGCA guidelines
2) Aged 20-80 years
3) Performance Status (ECOG) 0, 1, or 2
4) H. pylori infection was eradicated within 5 years or negative before enrollment
5) Will be followed over 5 years
6) Written informed consent

Key exclusion criteria

1) Allergy to aspirin treatment
2) Other gastric neoplasm including low grade adenoma remain
3) A history of H. pylori eradication therapy received more than 5 years ago
4) Lesions of Siewert Type II (<2 cm from the OGJ at the epicenter)
5) A history of gastric surgery
6) Severe co-morbidities and estimated life expectancy less than 3 years
7) Already on aspirin or other antithrombotic drugs prior to randomization
8) Using NSAIDs
9) Using Metformin
10) A history of peptic ulcers
11) A history of stroke
12) Receiving chemotherapy
13) Disorder of blood coagulation or platelet < 100,000/microliter
14) Pregnancy
15) Breast-feeding
16) Lack of informed consent

Target sample size

1120


Research contact person

Name of lead principal investigator

1st name Takuji
Middle name
Last name Gotoda

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine,

Zip code

101-8309

Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3293-1711

Email

takujigotoda@yahoo.co.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Suzuki

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine,

Zip code

101-8309

Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3293-1711

Homepage URL


Email

s.sho.salubriter.mail@gmail.com


Sponsor or person

Institute

MEGA trial Group

Institute

Department

Personal name



Funding Source

Organization

Japan Strategic Medical Administration Research Center: J-SMARC

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Nippon Medical School Foundation

Address

1-1-5, Sendagi, Bunkyoku, Tokyo, Japan

Tel

03-5802-8202

Email

officetokutei@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2019 Year 02 Month 04 Day

Date of IRB

2019 Year 02 Month 25 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2027 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 14 Day

Last modified on

2020 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035504


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name